Photo of Ritika  Vankina, M.D.

Ritika Vankina, M.D.

Assistant Professor of Medicine
NPI Number:
1811314263
Academic Office Location:
Carole and Ray Neag Comprehensive Cancer Center
UConn Health
263 Farmington Avenue
Farmington, CT 06030-8072
Phone: 800-579-7822
Website(s):

Carole and Ray Neag Comprehensive Cancer Center

  • Looking for a Physician?

    This faculty member is also
    a practicing physician at UConn Health.

    Learn more >
Education
DegreeInstitutionMajor
MBBSJ.J.M. Medical College/Rajiv Gandhi University of Health SciencesHealth Sciences
MPHUniversity of MassachusettsPublic Health

Post-Graduate Training
TrainingInstitutionSpecialty
FellowshipHarbor-UCLA Medical CenterHematology/Medical Oncology
ResidencyUMass Medical School-Baystate Medical CenterInternal Medicine

Awards
Name of Award/HonorAwarding Organization
Medicine Grand Rounds Geriatric Update Jeopardy - 1st PlaceUMass Medical School/Baystate Medical Center
Selected for Full Scholarship to Attend 2016 Southeast Center of Excellence in Geriatric Medicine Resident Award
Co-President of National Resident Section 2016American Geriatric Society
Recruitment Officer in Baystate Internal Medicine Residency Geriatric Track
Member of Research Track (2014-2016)

Abstracts

  • A Retrospective Assessment of Genomic Perturbations in a Plasma Cell Disorder Cohort at our Institution.
    Kumar S, Kirk K, Hooper K, Vankina R International Myeloma Society, Athens, Greece 2023.
  • A Retrospective Review Assessing the Development of Myelodysplastic Syndromes in Patients with Plasma Cell Dyscrasias
    Kirk K, Hooper K, Vankina R, Kumar S Blood 142((Supplement 1)):6499
  • An evaluation of patient workflow in hematology clinics at a university hospital referred for the workup of monoclonal gammopathy of undetermined significance (MGUS).
    Kumar S., Kulkarni R., Ozcan G., Tipirneni A., Vankina R., Baker WJ. Journal of Clinical Oncology 2021 39:28_suppl, 207-207
  • Thrombotic Significance in Plasma Cell Disorders: Do associated clonal hematopoiesis of indeterminate potential (CHIP) mutations increase the risk?
    Vankina R, Kirk K, Reddy A, Hooper K, and Kumar S. International Myeloma Society, Athens, Greece 2023. (S2, S1-S356, 2023):102
  • Utilization of the Khorana score (KS) by hematology/oncology clinicians in the ambulatory setting. ASCO Quality Care Symposium, Chicago 2022.
    Emmich M, Kidwai N, Holle L, and Vankina R. Ascopub

Case Reports

  • A case of gamma heavy chain disease: a rare B-cell disorder with successful therapeutic response.
    Clark J, Kumar S, Vankina R Northern New England Clinical Oncology Society
  • Acquired Hemophilia A and STEMI: A Management Dilemma.
    Jevin, Y., Lima G., Vankina R., Kumar S., and Meng J. Cureus. 2023 May 4;15(5):e38549. doi: 10.7759/cureus.38549. PMID: 37288205
  • Autoimmune hemolytic anemia as a harbinger of lymphoma
    Emmich M., Forbes V., Vankina R Northern New England Clinical Oncology Society
  • Normal karyotype FLT3 mutated Acute Myeloid Leukemia with Chronic Myeloid Leukemia; a rare diagnosis
    Kolandra L., Emmich M., Kapadia P., Vankina R 2021 International Congress on Myeloproliferative Neoplasms